Actively Recruiting
Pilot Study of CYTALUX Pafolacianine Injection to Help Detect Cancer During Surgery for Gastrointestinal, Esophageal, Pancreatic, Hepatobiliary, and Gynecologic Tumors
Led by John Waters · Updated on 2026-06-05
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating CYTALUX12 pafolacianine, an FDA-approved drug designed to help surgeons see cancer cells more clearly during surgery. This study focuses on adults with suspected or confirmed gastrointestinal, foregut, pancreatic, hepatobiliary, esophageal, or gynecologic cancers who are scheduled for surgery involving tumor removal or assessment. The main goal is to see if using CYTALUX with a special near-infrared camera can improve detection of malignant tissue that normal methods might miss. Participants will receive a single intravenous dose of CYTALUX between 1 and 24 hours before their surgery. During the operation, surgeons will use a near-infrared fluorescent imaging system to identify cancerous tissue highlighted by the drug. The surgical procedure continues as usual, supported by this imaging to guide tumor removal, lymph node assessment, and detection of hidden tumors. All patients receive the study drug in this single-arm pilot study. During the approximately two-month participation, researchers will monitor the presence of fluorescent lesions during surgery and compare them to standard detection methods. They will document additional malignant lesions found and assess how fluorescence matches confirmed cancer tissue. Safety of CYTALUX administration will also be tracked. The main measure is the number of extra cancerous spots identified with fluorescence that are missed by normal light or touch during surgery.
CONDITIONS
Brief Title
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
Research Team
J
John Waters, M.D.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here